Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-003706

Chief Executive Officer sold 34,446 shares at an average $20.61 ($709,873)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David Chief Executive Officer 2023-02-21 Sale −17,090 $20.93 $357,718 1,876,509 D: show line 1 in the form
Kirn David Chief Executive Officer 2023-02-21 Sale −907 $21.49 $19,491 1,875,602 D: show line 2 in the form
Kirn David Chief Executive Officer 2023-02-22 Sale −16,449 $20.22 $332,665 1,859,153 D: show line 3 in the form
Open-market sales · 34,446 sh · avg $20.61 · $709,873
Loading xslF345X03/doc1.xml…